Press release
Growth In Chronic Diseases Propels Transmucosal Drug Delivery Devices Market: Major Factor in the Transformation of the Transmucosal Drug Delivery Devices Market in 2025
Transmucosal Drug Delivery Devices Market Size
The market for transmucosal drug delivery devices has notably expanded in the past few years. The market worth, which currently stands at $50.24 billion in 2024, is predicted to increase to $55.04 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. This significant growth during the historical period can be ascribed to factors such as the urgent necessity for angina relief, the efficacy of sublingual delivery for immediate absorption into the bloodstream, the need to avoid gastrointestinal degradation, the advancement of buccal tablets, as well as the demand for non-invasive delivery of peptides and proteins._x000D_
_x000D_
The market for transmucosal drug delivery devices is projected to experience significant expansion in the coming years, increasing to $78.21 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%. This predicted growth during the forecast period can be ascribed to advancements in smart drug delivery systems, higher rates of chronic diseases, rising emphasis on personal medicine, an aging demographic requiring more medication, and growing awareness. Major forecasted patterns for this period include growth in therapeutic applications, personalization of drug delivery devices, regulatory approvals and guidelines, development in emerging markets, environment-friendly devices, and innovative recipes._x000D_
_x000D_
What Key Elements Are Boosting Growth in the Transmucosal Drug Delivery Devices Market?_x000D_
The escalating occurrence of chronic diseases is set to propel the expansion of the Transmucosal drug delivery devices market onwards. Chronic diseases, a term denoting enduring conditions that usually evolve slowly and persist for an extended period, frequently necessitate continuous medical management for symptom alleviation and complication prevention. Several factors contributing to the rise of chronic diseases include lifestyle behavior, an aging populace, environmental influences, challenges within the healthcare system and urbanization. Transmucosal drug delivery devices are utilized for these diseases, providing a regulated and effective medication delivery that ensures consistent therapeutic levels, aids in managing symptoms, and enhances patient compliance. For example, a report published by the US-based charity, the Leukemia & Lymphoma Society (LLS), stated in August 2023 that someone in the US is diagnosed with leukemia, lymphoma, or myeloma every three minutes. The report estimates that in 2023, roughly 184,720 individuals will be diagnosed with these conditions, amounting to 9.4% of the projected 1,958,310 new cancer incidences for that year. Hence, the increasing prevalence of chronic diseases is fueling the growth of the transmucosal drug delivery devices market._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp_x000D_
_x000D_
Who Are the Major Industry Players Fueling Transmucosal Drug Delivery Devices Market Expansion?_x000D_
Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd._x000D_
_x000D_
Which Key Developments Are Influencing the Transmucosal Drug Delivery Devices Market?_x000D_
Leading corporations in the field of transmucosal drug delivery devices are focusing on creating innovative intelligent platforms, such as exclusive transdermal patch delivery systems that are designed to boost drug absorption and increase patient adherence and convenience. These proprietary transdermal patch delivery systems pertain to unique technologies owned by corporations that facilitate medication administration through the skin, guaranteeing controlled drug release and improved healing results. For example, Starton Therapeutics Inc, a biotech company based in the US, launched a new exclusive transdermal patch delivery system named STARSILON in January 2024. The goal is to provide lengthy therapeutic delivery of APIs that are challenging to formulate. It broadens the scope of transdermal drug delivery options for complex active pharmaceutical ingredients (APIs), enhancing their medicinal potency through sustained delivery speeds._x000D_
_x000D_
How Is the Segmentation of the Transmucosal Drug Delivery Devices Market Defined?_x000D_
The transmucosal drug delivery devices market covered in this report is segmented -_x000D_
_x000D_
1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery_x000D_
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types_x000D_
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications_x000D_
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals_x000D_
_x000D_
Subsegments:_x000D_
1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems_x000D_
2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation_x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/transmucosal-drug-delivery-devices-global-market-report_x000D_
_x000D_
What Is the Leading Region in the Transmucosal Drug Delivery Devices Market?_x000D_
North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Is Covered In The Transmucosal Drug Delivery Devices Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the Transmucosal Drug Delivery Devices Market size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the Transmucosal Drug Delivery Devices Market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall Transmucosal Drug Delivery Devices Market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the Transmucosal Drug Delivery Devices Market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16812_x000D_
_x000D_
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growth In Chronic Diseases Propels Transmucosal Drug Delivery Devices Market: Major Factor in the Transformation of the Transmucosal Drug Delivery Devices Market in 2025 here
News-ID: 3868530 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
